HYPE crossed $56 on May 21 and Hyperliquid's fully diluted valuation overtook Solana's, while Bitwise and 21Shares ETFs combined for a record $25.5 million in net inflows the day before.
Hyperliquid's fully diluted valuation overtook Solana's on May 21, with the HYPE token climbing past $56 and the implied market cap of the project — assuming every token in the 962-million max supply is eventually unlocked — clearing $54 billion. Solana's FDV sits a few billion below that today. Six months ago, that flip would have been treated as a meme.
The flip is not the most important number in the comparison. Hyperliquid's circulating supply is roughly 254 million tokens — about 26 per cent of the maximum — while Solana has effectively all of its supply already in market. By the metric that actually decides what you pay for exposure, market capitalisation, Solana is still the larger asset by a wide margin. The FDV flip is a forward-looking bet on how Hyperliquid handles its unlocks; if the team has to sell into demand to fund operations, the gap closes again fast.
What is significant is the revenue. Bitwise's Hunter Horsley posted the chain-by-chain revenue league table this week and put Hyperliquid at $790 million cumulative, ahead of Solana at $532 million, Tron at $471 million, and — most awkwardly — Ethereum at $426 million. The revenue is fee-based; Hyperliquid charges a take on every perp filled on its orderbook, and the orderbook now does enough volume that the take is competitive with what L1s have been generating from gas in their best months. There is no MEV-extraction caveat to it and no inflation-funded reward bucket subsidising the number. It's just trading fees.
The institutional bid arrived this week. Bitwise launched BHYP on the NYSE on May 14, four days after 21Shares listed THYP. Yesterday those two ETFs combined pulled $25.5 million in net inflows — the strongest single session for any spot Hyperliquid product since it became possible to buy one. THYP's day-one inflow was $16.7 million; BHYP managed $8.8 million on its first day. By the standards of any ETF that isn't a bitcoin fund, those are large numbers. Peter Chung at Presto Research argued in a note this morning that, adjusted for market cap, institutions are buying HYPE ETFs faster than they bought bitcoin spot funds in early 2024.
The pitch the issuers are making has shifted in interesting ways. The first marketing decks for HYPE ETFs talked about token exposure. The current pitches from both Bitwise and 21Shares are talking about 24-hour markets and onchain orderbook depth — a recognition that the underlying isn't really a token, it's a working derivatives venue. That framing has more shelf life than "buy the protocol token" ever did.
The risk inside the rally is the same risk that's been inside it since November. Hyperliquid runs on a small validator set with a small amount of stake compared to the size of the asset it custodies, and the team has not been transparent about the long-term mechanics of the HYPE buyback or the operational structure underneath the orderbook. A protocol pulling in $790 million in fees ought to be one of the most carefully audited bits of infrastructure in the industry; in practice, the public security review is thin. The ETF wrappers are still buying spot tokens that depend on that infrastructure not breaking.
There is one more number that matters. Hyperliquid now dominates the decentralised perp market with roughly 63 per cent of open interest among DEX venues, and its share of total perp open interest across all exchanges sits in the low double digits — meaningful but still a fraction of where Bybit and Binance trade. Hyperliquid, in other words, is running on a chain that didn't exist three years ago, with a token that didn't exist eighteen months ago, and a market structure that has no obvious analogue in traditional finance. The institutional bid arriving through the ETF wrapper is what closes that gap.
Bitwise CEO Hunter Horsley's phrasing this week was that Hyperliquid and Solana are "the leaders" in revenue chains. He is not wrong on the order — Hyperliquid is in front. But Solana has revenue lines that aren't perp fees, and it has institutional integrations Hyperliquid won't match for years. The FDV crossover is real; the comparison underneath it is less symmetric than the headline.
